ArticleClinical rheumatology2026
Validity and reliability of the perseverative thinking questionnaire in patients with fibromyalgia.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with fibromyalgia often experience repetitive negative thinking, which contributes to psychological distress. The Perseverative Thinking Questionnaire (PTQ) is a tool designed to assess this cognitive pattern. However, its psychometric properties have not been tested in fibromyalgia.
objectiveThis study aimed to assess the validity and reliability of the PTQ in patients with fibromyalgia.
methodsA cross-sectional study was conducted in patients meeting the 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Participants were asked to complete the PTQ, Revised Fibromyalgia Impact Questionnaire (FIQR), Hospital Anxiety and Depression Scale (HADS), long version of the Ruminative Response Scale (RRS), and Short Form-12 (SF-12). Test-retest reliability was assessed over a 15-day interval. Internal consistency was evaluated using Cronbach's alpha, and construct validity was examined via Spearman's correlation analyses.
resultsThe study included 57 patients (55 female, 2 male) with a mean age of 45.1 ± 10.0 years. The PTQ demonstrated excellent internal consistency (Cronbach's alpha = 0.996) and test-retest reliability (intraclass correlation coefficient (ICC) = 0.992, 95% CI = 0.986 to 0.996, p < 0.001). Correlation analyses revealed that PTQ scores were strongly correlated with the RRS, HADS total, HADS-anxiety, HADS-depression, and SF-12 mental component scores, and moderately correlated with SF-12 physical component scores. Higher levels of perseverative thinking were associated with poorer physical, psychological, and mental health outcomes. However, a ceiling effect was detected, suggesting limited discrimination at the higher score range.
conclusionThe PTQ is a reliable and valid tool for assessing perseverative thinking in patients with fibromyalgia. The strong psychometric properties support its use in clinical and research settings. However, ceiling effects should be considered when interpreting scores. Key Points • The PTQ demonstrated excellent internal consistency and test-retest reliability in patients with fibromyalgia. • The PTQ demonstrated moderate-strong correlations with rumination, anxiety, depression, and quality of life. • The PTQ is a reliable and valid tool for assessing perseverative thinking in patients with fibromyalgia.
Indexed as
Identifiers
41350965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.